Price T Rowe Associates Inc Akouos, Inc. Transaction History

Price T Rowe Associates Inc

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 May 17, 2021	SELL	$13.87 - $21.04 $6.23 Million - $9.45 Million	-449,005 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$17.03 - $22.45 $7.65 Million - $10.1 Million	449,005 New	449,005 $8.9 Million

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.